Aripiprazole: Examining the Clinical Implications of D2 Affinity

被引：0
|
作者：
Anam, Adiba [1 ]
Lynch, Sean [1 ]
Mosharraf, Nafiz [1 ]
Soukas, Chloe [1 ]
Gekhman, Dmitriy [1 ,2 ]
机构：
[1] Mt Sinai Beth Israel, Dept Psychiat, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA
来源：
CNS SPECTRUMS | 2023年 / 28卷 / 02期
关键词：
D O I：
10.1017/S1092852923001232
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Affinity to different receptors and the rate of dissociation from the D2 receptors:: Their relation to the clinical effects of antipsychotics
    Vinar, O
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 189 - 189
  • [22] REACTION OF D3O+ WITH D2 - PROTON AFFINITY OF WATER
    COTTER, RJ
    KOSKI, WS
    JOURNAL OF CHEMICAL PHYSICS, 1973, 59 (02): : 784 - 787
  • [23] The temporal and extrastriatal D2/D3 receptor binding profile of aripiprazole in patients with schizophrenia
    Grunder, Gerhard
    Vernaleken, Ingo
    Boy, Christian
    Broeheler, Anno
    Fellows, Christine
    Janouschek, Hildegard
    Hellmann, Sandra
    Hiemke, Christoph
    Bartenstein, Peter
    Wong, Dean F.
    Roesch, Frank
    Buell, Ulrich
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S88 - S88
  • [24] Novel Bivalent Ligands for D2/D3 Dopamine Receptors: Significant Cooperative Gain in D2 Affinity and Potency
    Gogoi, Sanjib
    Biswas, Swati
    Modi, Gyan
    Antonio, Tamara
    Reith, Maarten E. A.
    Dutta, Aloke K.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 991 - 996
  • [25] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Paul W. Czoty
    H. Donald Gage
    Pradeep K. Garg
    Sudha Garg
    Michael A. Nader
    Psychopharmacology, 2014, 231 : 613 - 619
  • [26] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Czoty, Paul W.
    Gage, H. Donald
    Garg, Pradeep K.
    Garg, Sudha
    Nader, Michael A.
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 613 - 619
  • [27] Aripiprazole, a novel antipsychotic, is a potent partial agonist at human dopamine D2 receptors
    Burris, KD
    Molski, TF
    Ryan, E
    Xu, C
    Tottori, K
    Kikuchi, T
    Yocca, FD
    Molinoff, PB
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 88 - 88
  • [28] Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications
    De Haan, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S491 - S491
  • [29] Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: Clinical implications
    de Haan, L.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S85 - S86
  • [30] Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics:: Clinical implications
    de Haan, L
    Lavalaye, J
    van Bruggen, M
    van Nimwegen, L
    Booij, J
    van Amelsvoort, T
    Linszen, D
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2004, 49 (05): : 290 - 296
12345